Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTWN | ISIN: US82711P2011 | Ticker-Symbol:
NASDAQ
27.06.25 | 16:18
0,630 US-Dollar
-0,24 % -0,002
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SILO PHARMA INC Chart 1 Jahr
5-Tage-Chart
SILO PHARMA INC 5-Tage-Chart

Aktuelle News zur SILO PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSilo Pharma, Hoth Therapeutics Enter LOI to Develop Obesity Treatment1
MiHoth Therapeutics, Inc: Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market243NEW YORK, June 25, 2025 - (ACN Newswire) - Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery...
► Artikel lesen
MiSilo Pharma to form JV with Hoth Therapeutics for obesity treatment1
MiSilo Pharma and Hoth Therapeutics plan joint venture for obesity treatment2
MiHoth Therapeutics, Silo Pharma Launch JV To Commercialize VA-Invented Obesity Drug-
MiSilo Pharma, Inc.: Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market134Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental...
► Artikel lesen
11.06.Silo Pharma, Inc.: Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears400SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery...
► Artikel lesen
05.06.Silo Pharma stock surges on Bitcoin reserve move1
SILO PHARMA Aktie jetzt für 0€ handeln
05.06.Silo Pharma allocates $1 million to Bitcoin holdings1
05.06.Silo Pharma, Inc.: Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset265SARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery...
► Artikel lesen
21.05.Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug1
21.05.Silo Pharma advances PTSD treatment with new drug-device study2
21.05.Silo Pharma treibt PTBS-Behandlung mit neuer Medikamenten-Geräte-Studie voran5
21.05.Silo Pharma, Inc.: Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15231SARASOTA, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery...
► Artikel lesen
16.05.Silo Pharma, Inc. - 8-K, Current Report1
16.05.Silo Pharma, Inc.: Silo Pharma Announces Closing of $2 Million Public Offering1
15.05.Silo Pharma sets public offering at $0.60 per share and warrant1
15.05.Silo Pharma announces pricing of $2 million public offering3
15.05.Silo Pharma, Inc.: Silo Pharma Announces Pricing of $2 Million Public Offering1
14.05.Silo Pharma treibt PTBS-Behandlungsstudie mit Veloxity Labs voran1
Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1